Galapagos NV - stock earnings
GLPG Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | 27.3 million USD | 127.1 million USD |
2023Q2 | 5.5 million USD | 163.0 million USD |
2023Q1 | 25.3 million USD | 195.0 million USD |
2022Q4 | -222.4 million USD | 102.1 million USD |
2022Q3 | 21.1 million USD | 133.6 million USD |
2022Q2 | -19.9 million USD | 143.9 million USD |
2022Q1 | -14.9 million USD | 152.2 million USD |
2021Q4 | 18.6 million USD | 189.9 million USD |
2021Q3 | -74.8 million USD | 74.3 million USD |
2021Q2 | -76.3 million USD | 165.7 million USD |
2021Q1 | 11.0 million USD | 133.5 million USD |
2020Q4 | -70.5 million USD | 175.9 million USD |
2020Q3 | -96.1 million USD | 154.6 million USD |
2020Q2 | -129.3 million USD | 116.4 million USD |
2020Q1 | -55.8 million USD | 108.3 million USD |
2019Q4 | -129.4 million USD | 133.6 million USD |
2019Q3 | 395.3 million USD | 693.7 million USD |
2019Q2 | -53.7 million USD | 66.8 million USD |
2019Q1 | -54.6 million USD | 37.1 million USD |
2018Q4 | 17.1 million USD | 121.7 million USD |
2018Q3 | 17.3 million USD | 110.4 million USD |
2018Q2 | -25.2 million USD | 57.4 million USD |
2018Q1 | -45.9 million USD | 46.6 million USD |
2017Q4 | -35.6 million USD | 46.8 million USD |
2017Q3 | -43.1 million USD | 31.7 million USD |
2017Q2 | -40.8 million USD | 30.8 million USD |
2017Q1 | -14.5 million USD | 36.3 million USD |
2016Q4 | 48.3 million USD | 83.7 million USD |
2016Q3 | -27.1 million USD | 12.6 million USD |
2016Q2 | -4.1 million USD | 31.9 million USD |
2016Q1 | 40.7 million USD | 11.5 million USD |
2015Q4 | -62.3 million USD | 7.9 million USD |
2015Q3 | -30.6 million USD | 6.4 million USD |
2015Q2 | -22.4 million USD | 13.3 million USD |
2015Q1 | -15.4 million USD | 16.0 million USD |
2014Q4 | -12.5 million USD | 24.6 million USD |
2014Q3 | -15.7 million USD | 17.3 million USD |
2014Q2 | 104.4 million USD | 84.2 million USD |
2012Q4 | -13.1 million USD | 211.7 million USD |
GLPG Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 234.0 million USD | 265.0 million USD |
2022 | -233.9 million USD | 542.3 million USD |
2021 | -142.6 million USD | 551.4 million USD |
2020 | -378.8 million USD | 582.2 million USD |
2019 | 167.9 million USD | 946.6 million USD |
2018 | -33.5 million USD | 330.4 million USD |
2017 | -138.2 million USD | 151.8 million USD |
2016 | 56.8 million USD | 136.3 million USD |
2015 | -129.5 million USD | 43.3 million USD |
2014 | 40.4 million USD | 84.4 million USD |
2013 | -11.2 million USD | 190.2 million USD |
2012 | -7.5 million USD | 179.8 million USD |
2011 | -42.9 million USD | 124.2 million USD |
2010 | 5.8 million USD | 162.8 million USD |
2009 | 4.3 million USD | 133.4 million USD |
2008 | -20.3 million USD | 107.3 million USD |
2007 | -32.0 million USD | 96.3 million USD |
2006 | -15.0 million USD | 46.4 million USD |
2005 | -7.7 million USD | 13.3 million USD |
2004 | -4.9 million USD | 10.5 million USD |
GLPG
Price: $29.09
52 week price:
Earnings Per Share: -2.54 USD
P/E Ratio: -15.32
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 69406
Ebitda: -23.5 millionMarket Capitalization: 2.1 billion